{"id":29051,"date":"2023-08-18T12:18:33","date_gmt":"2023-08-18T11:18:33","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=29051"},"modified":"2023-08-18T12:18:36","modified_gmt":"2023-08-18T11:18:36","slug":"apply-to-join-the-enable-2-consortium","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/","title":{"rendered":"Apply to join the ENABLE-2 consortium"},"content":{"rendered":"\n

Open Call for new antibiotic programmes<\/h3>\n\n\n\n

ENABLE-2 is accepting applications from researchers at publicly-funded universities throughout Europe. The call is for novel Hit compounds with the potential for development as direct-acting antibiotics for systemic use.<\/strong><\/p>\n\n\n\n

The Call is Open Continuously<\/strong><\/em> but to be considered for entry at the next Portfolio Management Committee (PMC) meeting in November 2023 applications should reach us before 30th<\/sup> September 2023<\/strong>. Applications received after this date will be evaluated at the following PMC meeting in the spring 2024 (date to be decided).<\/p>\n\n\n\n

\n
Apply here<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Open Call for new antibiotic programmes ENABLE-2 is accepting applications from researchers at publicly-funded universities throughout Europe. The call is for novel Hit compounds with the potential for development as direct-acting antibiotics for systemic use. The Call is Open Continuously but to be considered for entry at the next Portfolio Management Committee (PMC) meeting in […]<\/p>\n","protected":false},"author":271,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[38],"tags":[6629,6607,6579,6623],"acf":[],"yoast_head":"\nApply to join the ENABLE-2 consortium - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apply to join the ENABLE-2 consortium - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-18T11:18:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-18T11:18:36+00:00\" \/>\n<meta name=\"author\" content=\"Loane Serrano\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Loane Serrano\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/\"},\"author\":{\"name\":\"Loane Serrano\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/7993978f184ff491165415f02259de61\"},\"headline\":\"Apply to join the ENABLE-2 consortium\",\"datePublished\":\"2023-08-18T11:18:33+00:00\",\"dateModified\":\"2023-08-18T11:18:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/\"},\"wordCount\":91,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"keywords\":[\"AAP\",\"Antibior\u00e9sistance\",\"antimicrobial\",\"Financements\"],\"articleSection\":[\"Appels \u00e0 projets\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/\",\"name\":\"Apply to join the ENABLE-2 consortium - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"datePublished\":\"2023-08-18T11:18:33+00:00\",\"dateModified\":\"2023-08-18T11:18:36+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info & communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Calls for projects\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Apply to join the ENABLE-2 consortium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/7993978f184ff491165415f02259de61\",\"name\":\"Loane Serrano\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Apply to join the ENABLE-2 consortium - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/","og_locale":"en_GB","og_type":"article","og_title":"Apply to join the ENABLE-2 consortium - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2023-08-18T11:18:33+00:00","article_modified_time":"2023-08-18T11:18:36+00:00","author":"Loane Serrano","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Loane Serrano"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/"},"author":{"name":"Loane Serrano","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/7993978f184ff491165415f02259de61"},"headline":"Apply to join the ENABLE-2 consortium","datePublished":"2023-08-18T11:18:33+00:00","dateModified":"2023-08-18T11:18:36+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/"},"wordCount":91,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"keywords":["AAP","Antibior\u00e9sistance","antimicrobial","Financements"],"articleSection":["Appels \u00e0 projets"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/","name":"Apply to join the ENABLE-2 consortium - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"datePublished":"2023-08-18T11:18:33+00:00","dateModified":"2023-08-18T11:18:36+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/appels-a-projets\/apply-to-join-the-enable-2-consortium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info & communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"Calls for projects","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/"},{"@type":"ListItem","position":4,"name":"Apply to join the ENABLE-2 consortium"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/7993978f184ff491165415f02259de61","name":"Loane Serrano"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-05-07 00:42:51","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/29051"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/271"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=29051"}],"version-history":[{"count":2,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/29051\/revisions"}],"predecessor-version":[{"id":29055,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/29051\/revisions\/29055"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=29051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=29051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=29051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}